Search

Displaying results 9181 - 9190 of 10000 in total
  1. Drug

    Dersalazine

    go.drugbank.com/drugs/DB06251
    Investigational

  2. Drug

    Refametinib

    go.drugbank.com/drugs/DB06309
    Investigational

  3. Drug

    Naxifylline

    go.drugbank.com/drugs/DB06471
    Experimental

  4. Drug

    MLN2222

    go.drugbank.com/drugs/DB06503
    Experimental

    MLN2222 is a novel, proprietary recombinant protein that blocks both the C3 and C5 convertases, which are essential components of the complement activation pathway.

  5. Drug

    Lerdelimumab

    go.drugbank.com/drugs/DB06557
    Experimental

  6. Drug

    AM365

    go.drugbank.com/drugs/DB06564
    Experimental

    Detiviciclovir (AM365) is an antiviral nucleoside analogue.

  7. Drug

    Triphendiol

    go.drugbank.com/drugs/DB06588
    Experimental

  8. Drug

    Valtorcitabine

    go.drugbank.com/drugs/DB06187
    Investigational

  9. Drug

    Celgosivir

    go.drugbank.com/drugs/DB06580
    Investigational

  10. Drug

    IR208

    go.drugbank.com/drugs/DB05106
    Investigational

    IR208 is currently undergoing Phase II studies in a 200-patient trial. … IR208 is a synthetic T-Cell receptor peptide vaccine developed by Immune Response Corporation.